The redundancy of the concept of ‘spirit of sport’ in discussions on the prohibited list of doping substances

References

• Campos, D.R., Yonamine, M., and De Moraes Moreau, R.L., 2003. Marijuana as doping in sports. Sports medicine, 33, 395–399. doi:10.2165/00007256-200333060-00001
   PubMed Web of Science ®Google Scholar
• Gleaves, J., 2015. The prohibited list and its implications. In: V. Møller, I. Waddington, and J. Hoberman, eds.. Routledge Handbook of Drugs and Sport. Abingdon, United Kingdom: Routledge.
   Google Scholar
• Gomez, J., 2005. Use of performance-enhancing substances. Pediatrics, 115, 1103–1106. doi:10.1542/peds.2005-0085
   PubMed Web of Science ®Google Scholar
• Hartgens, F. and Kuipers, H., 2004. Effects of androgenic-anabolic steroids in athletes. Sports medicine, 34, 513–554. doi:10.2165/00007256-200434080-00003
   PubMed Web of Science ®Google Scholar
• Health Council of the Netherlands, 2010. Doping in unorganised sports. The Hague, the Netherlands: H.C.O.T. Netherlands.
   Google Scholar
• Heuberger, J.A., et al., 2012. Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit. British journal of clinical pharmacology.
   Web of Science ®Google Scholar
• Houlihan, B., 1999. Dying to win - doping in sport and the development of anti-doping policy. Strasbourg, France: Council of Europe Publishing.
   Google Scholar
• Huestis, M.A., Mazzoni, I., and Rabin, O., 2011. Cannabis in sport: anti-doping perspective. Sports medicine, 41, 949–966. doi:10.2165/11591430-000000000-00000
   PubMed Web of Science ®Google Scholar
• Ioc, 2015. Olympic Charter, in force as from 2 August 2015. In: I.O. Committee, ed.. Lausanne: Switserland.
   Google Scholar
• Iaaf, 1928. A piece of anti-doping history: IAAF Handbook 1927-1928 [online]. http://www.iaaf.org/news/news/a-piece-of-anti-doping-history-iaaf-handbook
   Google Scholar
• Kayser, B., Mauron, A., and Miah, A., 2005. Viewpoint: legalisation of performance-enhancing drugs. Lancet, 366 (Suppl 1), S21. doi:10.1016/S0140-6736(05)67831-2
   PubMed Web of Science ®Google Scholar
• Kayser, B., Mauron, A., and Miah, A., 2007. Current anti-doping policy: a critical appraisal. BMC medical ethics, 8, 2. doi:10.1186/1472-6939-8-2
   PubMedGoogle Scholar
• Kornbeck, J., 2013. The naked spirit of sport: a framework for revisiting the system of bans and justifications in the World Anti-Doping Code. Sport, Ethics and Philosophy, 313–330. doi:10.1080/17511321.2013.831115
   Google Scholar
• Kuipers, H. and Ruijsch Van Dugteren, G., 2006. The prohibited list and cheating in sport. International journal of sports medicine, 27, 80–82. doi:10.1055/s-2005-873069
   PubMed Web of Science ®Google Scholar
• Loland, S. and Hoppeler, H., 2011. Justifying anti-doping: the fair opportunity principle and the biology of performance enhancement. European Journal of Sport Science, 1–7.
   Web of Science ®Google Scholar
• Malloy, D.C., Kell, R., and Kelln, R., 2007. The spirit of sport, morality, and hypoxic tents: logic and authenticity. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 32, 289–296. doi:10.1139/H07-013
   PubMed Web of Science ®Google Scholar
• Mcnamee, M.J., 2012. The spirit of sport and the medicalisation of anti-doping: empirical and normative ethics. Asian Bioethics Review, 4, 374–392.
   Google Scholar
• Mcnamee, M.J., 2015. The spirit of sport and the world anti-doping code. In: V. Møller, I. Waddington, and J. Hoberman, eds.. Routledge Handbook of Drugs and Sport. Abingdon, United Kingdom: Routledge.
   Google Scholar
• Mcnamee, M.J. and Tarasti, L., 2010. Juridical and ethical peculiarities in doping policy. Journal of medical ethics, 36, 165–169. doi:10.1136/jme.2009.030023
   PubMed Web of Science ®Google Scholar
• Miah, A., 2005. Doping and the child: an ethical policy for the vulnerable. Lancet, 366, 874–876. doi:10.1016/S0140-6736(05)67296-0
   PubMed Web of Science ®Google Scholar
• Montalvan, B. and Duclos, M., 2008. Why glucocorticoids ought to be kept on the World Antidoping Agency’s list of banned products. British journal of sports medicine, 42, 946–947. doi:10.1136/bjsm.2008.053397
   PubMed Web of Science ®Google Scholar
• Mottram, D.R., 1999. Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating? Sports medicine, 27, 1–10. doi:10.2165/00007256-199927010-00001
   PubMed Web of Science ®Google Scholar
• Müller, R.K., 2010. History of doping and doping control. Handbook of experimental pharmacology, 195, 1–23.
   PubMedGoogle Scholar
• Orchard, J.W., 2008. Why glucocorticoids should be removed from the World Antidoping Agency’s list of banned products. British journal of sports medicine, 42, 944–945. doi:10.1136/bjsm.2008.053371
   PubMed Web of Science ®Google Scholar
• Petrou, M.J., 2006. Re: Kuipers H, Ruijsch van Dugteren G. Letter to the editors - the prohibited list and cheating in sport. Int J Sports Med 2006; 27: 80-82. International journal of sports medicine, 27, 83–84. doi:10.1055/s-2005-873070
   PubMed Web of Science ®Google Scholar
• Pigozzi, F., et al., 2012. Why glucocorticosteroids should remain in the list of prohibited substances: a sports medicine viewpoint. International journal of immunopathology and pharmacology, 25, 19–24. doi:10.1177/039463201202500103
   PubMed Web of Science ®Google Scholar
• Pluim, B.M., et al., 2011. Beta-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials. Sports medicine, 41, 39–57. doi:10.2165/11537540-000000000-00000
   PubMed Web of Science ®Google Scholar
• Ritchie, I., 2013. The construction of a policy: the World Anti-Doping Code’s ‘spirit of sport’ clause. Performance Enhancement & Health, 2, 194–200. doi:10.1016/j.peh.2014.10.002
   Google Scholar
• Savulescu, J., Foddy, B., and Clayton, M., 2004. Why we should allow performance enhancing drugs in sport. British journal of sports medicine, 38, 666–670. doi:10.1136/bjsm.2003.005249
   PubMed Web of Science ®Google Scholar
• Schneider, A.J., 2015. The concept of doping. In: V. Møller, I. Waddington, and J. Hoberman, eds.. Routledge Handbook of Drugs and Sport. Abingdon, United Kingdom: Routledge.
   Google Scholar
• Wada, 2003a. Referenced review of specific substances: removal of substances of the list [online]. World Anti-Doping Agency. Available from: http://www.doping.nl/filter/doc:3993/WADA%20Prohibited%20list%20-%20Referenced%20Review%20Of%20Specific%20Substances%20%3A%20Removal%20Of%20Substances%20Of%20The%20List%20%5B2003%5D [Accessed 2016].
   Google Scholar
• Wada, 2003b. World anti-doping code. Montreal, Canada: World Anti-Doping Agency.
   Google Scholar
• Wada, 2015. World anti-doping code. Montreal, Canada: World Anti-Doping Agency.
   Google Scholar
• Wiesing, U., 2011. Should performance-enhancing drugs in sport be legalized under medical supervision? Sports medicine, 41, 167–176. doi:10.2165/11537530-000000000-00000
   PubMed Web of Science ®Google Scholar